In this study, the easily obtained and representative biomarkers fibrinogen, ALB, and NLR were combined with the common endometrial cancer antigen marker CA125, which comprehensively reflected the systemic state of patients and established effective clinical prediction models. The gene discussed is ALB; the disease is endometrial cancer.